Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1820-1824

  Sano, Tetsuro ^a   Lin, Huai ^a   Chen, Xiashan ^a   Langford, Lauren A ^a   Koul, Dimpy ^a   Bondy, Melissa L ^a   Hess, Kenneth R ^a   Myers, Jeffrey N ^a   Hong, Yong Kil ^a   Yung, W K Alfred ^a   Steck, Peter A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CHROMOSOME 10Q; GENE LOCATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORIC MONOESTER HYDROLASES; PROGNOSIS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0033561655     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davis, F. G., Freels, S, Gnitsch, J., Barlas, S., and Brem, S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991. J. Neurosurg., 88: 1-10, 1998.
2. Louis, D. N. A molecular genetic model of astrocytomas histopathology. Brain Pathol., 7: 755-764, 1997.
3. Fults, D., and Pedone, C. A. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer, 7: 173-177, 1993.
4. Lin, H., Bondy, M. L., Langford, L. A., Hess, K. R., Delcolos, G. L., Wu, X., Chan, W., Pershouse, M. A., Yung, W. K. A., and Steck, P. A. Allelic deletion analyses of MMAC/PTEN and DMBTI loci in gliomas: relationship to prognostic significance. Clin. Cancer Res., 4: 2447-2454, 1998.
5. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A., Langford, L. A., Baumgard, M. L., Hattie, R. T., Davis, T., Frye, C., Hu, R., Swedlund B., Teng, D. H. F., and Tavtigian S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
6. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Persons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
7. Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A., and Poustka, A. DMBTI, a new member of the SRCR superfamily on chromosome 10q25.3-26.1, is deleted in malignant brain tumours. Nat. Genet., 17: 32-39, 1997.
8. Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Persons, R., and Tonks, N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 94: 9052-9057, 1997.
9. Maehama, T., and Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem., 273: 13375-13378, 1998.
10. Furnari, F. B., Lin, H., Huang, H. J. S., and Cavenee, W. K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA, 94: 12479-12484, 1997.
11. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Persons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
12. Eng, C., and Peacocke, M. PTEN and inherited hamartoma-cancer syndromes. Nat. Genet., 19: 223, 1998.
13. Teng, D. H. F., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., Ellis, L., El-Naggar, A., Frazier, M., Jasser, S., Langford, L. A., Lee, J., Mills, G. B., Pershouse, M. A., Pollack, R. E., Tornos, C., Troncoso, P., Yung W. K. A., Fujii, G., Berson, A., Bookstein, R., Bolen, J. B., Tavtigian, S. V., and Steck, P. A. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57: 5221-5225, 1997.
14. Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., Said, J. W., Isaacs, W. B., and Sawyers, C. L. Inactivation of the tumor suppressor PTEN/ MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad. Sci. USA, 95: 5246-5250, 1998.
15. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barnett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57: 4736-4738, 1997.
16. Li, D-M., and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor-β. Cancer Res., 57: 2124-2129, 1997.
17. Rasheed, B. K. A., Stenzel, T. T., McLendon, R. E., Parsons, R., Friedman, A. H., Friedman, H. S., Bigner, D. D., and Bigner, S. H. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res., 57: 4187-4190, 1997.
18. Cairns, P., Okami, K., Halachimi, S., Halachimi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S., and Sidransky, D. Frequent inactivation of PTEN/ MMAC1 in prostate cancer. Cancer Res., 57: 4997-5000, 1997.
19. Guldberg, P., Straten, P. T., Birck, A., Ahrenkiel, V., Kirkin, A. F., and Zeuthen, J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57: 3660-3663, 1997.
20. Wang, S. I., Parsons, R., and Ittmann, M. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin. Cancer Res., 4: 811-815, 1998